Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Myocet (Non-pegylated liposomal doxorubicin (NPLD))|DRUG: Paclitaxel|DRUG: Lapatinib (GW572016, Tykerb)
Sponsor: Prof Dirk Elling